Prophylactic use of aromatase inhibitor is effective in decreasing the incidence of Gestational Trophoblastic Neoplasia (GTN) in patients with complete hydatidiform mole (CHM)
Age range
20 Years – 40 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
(β-hCG) level
Timeframe: at the first day of evacuation
(β-hCG) level
Timeframe: one month after evacuation
(β-hCG) level
Timeframe: two months after evacuation
(β-hCG) level
Timeframe: three months after evacuation
(β-hCG) level
Timeframe: four months after evacuation
(β-hCG) level
Timeframe: Five months after evacuation
(β-hCG) level
Timeframe: Six months after evacuation